Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Paired Box 8 (PAX8) (Middle Region) Peptide

PAX8 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN2185325

Quick Overview for Paired Box 8 (PAX8) (Middle Region) Peptide (ABIN2185325)

Target

PAX8 (Paired Box 8 (PAX8))

Origin

Human

Source

  • 13
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    YSINGLLGIA QPGSDKRKMD DSDQDSCRLS IDSQSSSSGP RKHLRTDAFS

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-PAX8 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeat freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PAX8 (Paired Box 8 (PAX8))

    Background

    PAX8 is a member of the paired box (PAX) family of transcription factors. Members of this family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. This nuclear protein is involved in thyroid follicular cell development and expression of thyroid-specific genes. Mutations in its gene have been associated with thyroid dysgenesis, thyroid follicular carcinomas and atypical follicular thyroid adenomas.

    Protein Size: 450

    Molecular Weight

    48 kDa

    Gene ID

    7849

    UniProt

    Q06710
You are here:
Chat with us!